OSI Group has the most impressive record in its operations that spans for more than 100 years. The food processing company was established by Otto Kolschowsky in 1909 as a butchery and a meat market joint in Chicago. Back then it was called Otto & Sons, but after years it was rebranded to OSI Industries and later OSI Group. Currently, the company stands to be the largest firm, with more than 65 facilities across the world. It was once featured in the Forbes as the largest company. Sheldon Lavin serves as the CEO at the OSI Group and focuses more on green practices and sustainability as well as food safety. Lavin is committed to the growth and expansion of the company by use of strategic sales methods.
Additionally, innovative leadership and practices give the OSI Group expansion benefits. The company has consistently continued to expand through the acquisition of other various food companies in different continents. OSI Industries provides custom solutions in food products as well as high-quality products for retail industries and consumers.
In 2016, the firm reflected expansion by purchasing seven new food facilities which had the same goals and value just like OSI Industries. From the acquisition of Flagship Europe,the company provides food products for new customers in the world market. The clients will get frozen poultry, pies, sandwich, marinades, sauces, among others. According to the President of OSI Group David McDonald, the purchase of Flagship Europe created an extensive market. Furthermore, acquisition of the Baho Food based in Netherlands and Germany has expanded the demand for the OSI food products.
OSI Industries has its headquarters in Aurora, Illinois. The company produces food products rich in proteins where some of them are packed and sold to the retail trade globally and others consumed from their leading restaurants. It has focused not only on international expansion but also for domestic growth. They acquired a food plant in Chicago which used to be operated by Tyson Foods. OSI Group purchased it so that it can retain 500 employees who were about to lose their source of income due to its closure. They have always diversified in their production to meet the needs of every consumer.
However, ensuring such a large company remains at its higher level requires exceptional managerial skills and marketing strategies. Through the years, the leaders have been focused on the goals of the firm. The company has remained close to the people of Illinois and the Ronald McDonald House. ISO is known for its contributions to charitable causes like Feeding America.
OSI Group Info: www.foodworks.pl/en/osi-group-en.html
Mikhail Blagosklonny is a revered New York-based professor of oncology who has made significant contributions in cancer treatment. He currently works at the Buffalo-based Rosewell Park Cancer Institute and has done a lot of research about cancer therapies. Blagosklonny also works at Oncotarget where he is the editor-in-chief and has published a lot of research work that focuses on aging. He is recognized for promoting the use of a cancer drug that is called Rapamycin. He believes that the cure can significantly increase the lives of cancer patients. The professor has made great accomplishments during his career life. Rapamycin is a drug that was formed to prevent rejections during organ transplants. It is also known as Sirolimus. Other uses of the drug include curing a rare lung disease, hemolytic-uremic syndrome, lymphangioleiomyomatosis (LAM), facial angiofibromas, tuberous sclerosis complex (TSC), and coating coronary stents. Its trade name in the pharmaceuticals world is Rapamune and is recognized as a cancer drug. Rapamycin was first created in 1972 from bacteria samples that were discovered on Eastern Island. It was first used as an anti-fungal agent before scientists found out that it had antiproliferative and immunosuppressive properties.
Blagosklonny has been working to ensure that cancer patients get the best cures since he believes that human life is valuable. The main areas that he has been dealing with in the medical research world are aging and cancer treatment. He is focused on linking the two fields since cancer mostly affects old people who are past a certain age. Mikhail is determined to conduct research that will be beneficial to the oncology world. His success as a professor in the field has made him be an inspiration to his peers and students.The scientist attended First Pavlov State Medical University of St. Peterburg where he completed his master’s degree in internal medicine before enrolling for his Ph.D. in cardiology and experimental medicine at the institution. He was hired by the Valhalla-based New York Medical College in 2002 and later become a senior scientist at the Ordway Research Institute.
Mikhail worked at the organization until 2009 when he got a chance to serve Roswell Park Cancer Institute as a professor of oncology. The professor has developed an interest in researching about targeted cancer therapies that the prevent health human body cells from being damaged. He has also been studying the mechanism of aging and the development of anti-aging drugs. Mikhail has come up with a hypothesis that tries to explain the role of TOR signaling in cancer and aging. He has advised medical practitioners to use rapamycin in lengthening their cancer patients’ lives.he professor has also been involved in editorial undertakings. He acts as editor-in-chief of oncotarget, cell cycle, and aging. Mikhail is also a cancer biology and therapy associate editor and has been part of the cell death and differentiation editorial board. He has written hundreds of research papers, book chapters, and articles about cancer treatment. His work at the Rosewell Park Cancer Institute is greatly acknowledged.
Adam Milstein is a managing partner for Hager Pacific Properties. Hager Pacific Properties has held over $2 billion dollars in properties across the world. Though Milstein loves his job as a real estate investor he takes pride in giving back to the community. Milstein is one of the most recognized philanthropists in philanthropy. Milstein and his wife have created the Gila Milstein Family Foundation. The foundation mentor’s students across the world to learn more about their Jewish roots and have a deeper connection to Israel. This year Milstein was recognized as one of the 200 Most influential Do-Gooders. Adam and his wife are also co-founders to the Sifriyat Pajama B`America organization. This organization donates free books that are transcribed in Hebrew while achieving information on the Jewish values. Adam Milstein is a part of several organizations such as the Stand With Us organization, Israel on Campus Coalition, Hasbara Fellowships, Jewish Funders Network, Birthright Israel and so much more. Adam Milstein has been a philanthropist for a long time and during that time has contributed his time to over 100 organizations. Adam Milstein lives by three principles that will help to be an active philanthropist; the first is charitable work is a lifetime labor of love, the second stay focused, but find synergies and the third is put your money where your mouth is. Adam Milstein is a committed person when it comes to philanthropy. Since the beginning, Adam has changed the lives of pro-Israel Americans and strengthening their alliance. Milstein has stated that being a philanthropist is a full-time job. Adam does not consider being a philanthropist to being a job but something that is done from the heart, love, and passion. Adam Milstein is devoted to being a part of his foundation and many more organizations. Adam Milstein displays perseverance and strength to accomplish any goal that anyone wants to achieve.
To know more click here
Daniel Mark Harrison is a very well renowned entrepreneur, author and is also the Chairman & Chief Executive Officer of global investment company Daniel Mark Harrison & Co. (DMH&CO), He is a Managing Partner of FinTech venture capital firm Monkey Capital. As well as being the author of The Millennial Reincarnations, a novel he published that was in 2015. This was only made possible after his life of working on and creating recommendations and researching consistently to learn.
Money Capital is a hedge fund investing in the SpaceX supply and contracts the Blockchain systems. Monkey Capital has received extended acknowledgment
, for 6 out of a five star rating from the United States national radio host Chris Waltzek, who gave his rating to Harrison the company’s founder and manager. Harrison was also a publisher and Editor in Chief at Marx Rand. Marx Rand is a news publication focusing on peoples minds. He was a columnist
for 6 years at the Motley fool from the year 2009 to the year of 2015 and was said to have made recommendations pertaining to stock prices in the US and UK that were great.
Harrison went forward and said that the goal for him is to make history by being one of the first to create crowd funding options correctly. Monkey Capital’s solution, which stems around splitting up the votes by using voting and non voting shares and placing itself as the only recipient of dividends but not as the fund’s every day administrative manager. “Monkey Capital has key elements of a successful crypto project a bold but realistic plan, strong team with a delivery track record and transparency in terms of who they are and how they plan to deliver results,” Alex Michaelis, co-founder of Coinschedule.com said in an e-mail response to Monkey Capital.